Physician profile

Bradford J Stevenson

Urology · Ogden, UT

NPI 1710298047

$9,619.65

in general payments reported to CMS, 2019-2025

45 companies · $2,019 in 2025

The $2,019 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,161.94
Education$393.11

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $2,945.59 2019-2025 Lithovue, Rezum Generator, Tria Firm
Astellas Pharma US INC $1,284.72 2019-2025 Xtandi, Veozah, Myrbetriq
Abbvie INC. $786.32 2019-2025 Botox, Lupron Depot
Pfizer INC. $422.68 2019-2025
Sumitomo Pharma America, INC. $398.20 2023-2025 Orgovyx, Gemtesa
Dendreon Pharmaceuticals LLC $360.48 2019-2024 Provenge
Endo Pharmaceuticals INC. $332.41 2019-2024 Xiaflex, Aveed
Calyxo, INC. $251.30 2024-2025 Cvac Aspiration System
Rochester Medical Corporation $226.89 2022
Medtronic, INC. $223.90 2022-2025 Interstim, Signia
Janssen Biotech, INC. $197.13 2019-2024 Erleada
Myovant Sciences INC. $193.25 2021-2022
180 Medical, INC. $158.85 2019-2025
Allergan, INC. $142.88 2019-2022
Fujifilm Healthcare Americas Corporation $132.61 2022
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Urogen Pharma, INC. $120.85 2021-2025 Jelmyto
Travere Therapeutics, INC. $118.69 2019-2022
Dornier Medtech America, INC $109.54 2025 Dornier Medtech
Amgen INC. $101.30 2019-2022
Endo USA, INC. $90.54 2024-2025 Xiaflex, Aveed
Axonics, INC. $89.92 2021-2023 Bulkamid, Axonics
Laborie Medical Technologies Corp. $88.79 2023-2025
Urovant Sciences INC $73.33 2021-2022
Intuitive Surgical, INC. $70.58 2020
Bayer Healthcare Pharmaceuticals INC. $67.44 2019-2025
Accord Healthcare, INC. $64.84 2024-2025
Ferring Pharmaceuticals INC. $55.44 2024-2025 Adstiladrin
Coloplast Corp $54.58 2019-2021
Progenics Pharmaceuticals, INC. $51.89 2023-2025 Pylarify
Antares Pharma, INC. $50.58 2019-2024 Xyosted
Novo Nordisk INC $49.85 2024-2025 Rivfloza
Merck Sharp & Dohme LLC $46.55 2020-2025 Lynparza
Olympus America INC. $45.46 2023-2025 Itind System
Ambu INC. $33.82 2023
Kowa Pharmaceuticals America, INC. $28.89 2022-2023 Seglentis
Photocure INC $22.42 2019-2021
Verity Pharmaceuticals INC. $17.33 2025 Trelstar
Abc Home Medical Supply, INC. $16.99 2024
Alnylam Pharmaceuticals INC. $16.59 2025 Oxlumo
Davol INC. $15.10 2021
Otsuka America Pharmaceutical, INC. $14.69 2023 Jynarque
Medtronic USA, INC. $14.08 2020
Neotract INC. $11.91 2020
Myriad Genetic Laboratories, INC. $11.21 2021
Valencia Technologies Corporation $9.24 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bradford J Stevenson

$9,619.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $2,019 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/349511/bradford-j-stevenson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.